Investors Financial Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Investors Financial Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,541	Closed	-$1.64M	–	211
2021 Q1	$1.64M	Sell	7,541 -600	-7%	-$113K	0.96%	23
2020 Q4	$940K	Sell	8,141 -2,142	-21%	-$240K	0.62%	47
2020 Q3	$1M	Buy	10,283 +1,973	+24%	+$227K	0.75%	30
2020 Q2	$1.02M	Buy	8,310 +979	+13%	+$111K	0.84%	30
2020 Q1	$642K	Buy	7,331 +2,510	+52%	+$266K	0.65%	41
2019 Q4	$504K	Buy	+4,821	New	+$541K	0.41%	69

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Investors Financial Group's GWPH Position: Q2 2021 in Review

Investors Financial Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 7,541 shares — an estimated $1.64M sold.

Investors Financial Group first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $1.64M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Investors Financial Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Investors Financial Group sold 7,541 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.64M.
Investors Financial Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
Investors Financial Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.64M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Investors Financial Group's 13F filing for Q2 2021, filed 29 Jul 2021.